Literature DB >> 19902173

Human IL6 enhances leptin action in mice.

M Sadagurski1, L Norquay, J Farhang, K D'Aquino, K Copps, M F White.   

Abstract

AIMS/HYPOTHESIS: Interleukin-6 is an inflammatory cytokine with pleiotropic effects upon nutrient homeostasis. Many reports show that circulating IL6 correlates with obesity and contributes to insulin resistance; however, IL6 can promote energy expenditure that improves glucose homeostasis.
METHODS: We investigated nutrient homeostasis in C57BL/6J mice with sustained circulating human IL6 (hIL6) secreted predominantly from brain and lung (hIL6(tg) mice).
RESULTS: The hIL6(tg) mice displayed no features of systemic inflammation and were more insulin-sensitive than wild-type mice. On a high-fat diet, hIL6(tg) mice were lean, had low leptin concentrations, consumed less food and expended more energy than wild-type mice. Like ob/ob mice, the ob/ob (IL6) mice (generated by intercrossing ob/ob and hIL6(tg) mice) were obese and glucose-intolerant. However, low-dose leptin injections increased physical activity and reduced both body weight and food intake in ob/ob (IL6) mice, but was ineffective in ob/ob mice. Leptin increased hypothalamic signal transducer and activator of transcription-3 phosphorylation in ob/ob (IL6) mice, whereas ob/ob mice barely responded. CONCLUSIONS/
INTERPRETATION: Human IL6 enhanced central leptin action in mice, promoting nutrient homeostasis and preventing diet-induced obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19902173      PMCID: PMC2815798          DOI: 10.1007/s00125-009-1580-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

1.  Critical role of STAT3 in leptin's metabolic actions.

Authors:  Christoph Buettner; Alessandro Pocai; Evan D Muse; Anne M Etgen; Martin G Myers; Luciano Rossetti
Journal:  Cell Metab       Date:  2006-07       Impact factor: 27.287

2.  Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.

Authors:  Hiroshi Inoue; Wataru Ogawa; Akihiro Asakawa; Yasuo Okamoto; Akihiko Nishizawa; Michihiro Matsumoto; Kiyoshi Teshigawara; Yasushi Matsuki; Eijiro Watanabe; Ryuji Hiramatsu; Kenji Notohara; Koji Katayose; Hitoshi Okamura; C Ronald Kahn; Tetsuo Noda; Kiyoshi Takeda; Shizuo Akira; Akio Inui; Masato Kasuga
Journal:  Cell Metab       Date:  2006-04       Impact factor: 27.287

3.  Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth.

Authors:  Xiaocheng Dong; Sunmin Park; Xueying Lin; Kyle Copps; Xianjin Yi; Morris F White
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

4.  IL-6-overexpression brings about growth impairment potentially through a GH receptor defect.

Authors:  Jaroslava Lieskovska; Donglin Guo; Eva Derman
Journal:  Growth Horm IGF Res       Date:  2002-12       Impact factor: 2.372

Review 5.  Cytokines in aging and exercise.

Authors:  B K Pedersen; H Bruunsgaard; K Ostrowski; K Krabbe; H Hansen; K Krzywkowski; A Toft; S R Søndergaard; E W Petersen; T Ibfelt; P Schjerling
Journal:  Int J Sports Med       Date:  2000-05       Impact factor: 3.118

6.  Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice.

Authors:  A Katsume; T Miyai; H Suzuki; Y Moriguchi; H Kawata; T Tatsumi; S Suematsu; T Kishimoto; Y Ohsugi
Journal:  Clin Immunol Immunopathol       Date:  1997-02

7.  Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF.

Authors:  Björn Schuster; Marina Kovaleva; Yi Sun; Petra Regenhard; Vance Matthews; Joachim Grötzinger; Stefan Rose-John; Karl-Josef Kallen
Journal:  J Biol Chem       Date:  2003-03-14       Impact factor: 5.157

Review 8.  IL-6 signalling in exercise and disease.

Authors:  B K Pedersen
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

Review 9.  Acquiring signalling specificity from the cytokine receptor gp130.

Authors:  Matthias Ernst; Brendan J Jenkins
Journal:  Trends Genet       Date:  2004-01       Impact factor: 11.639

10.  IgG1 plasmacytosis in interleukin 6 transgenic mice.

Authors:  S Suematsu; T Matsuda; K Aozasa; S Akira; N Nakano; S Ohno; J Miyazaki; K Yamamura; T Hirano; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  50 in total

1.  Deletion of interleukin-6 improves pyruvate tolerance without altering hepatic insulin signaling in the leptin receptor-deficient mouse.

Authors:  Alicia H Clementi; Allison M Gaudy; Teresa A Zimmers; Leonidas G Koniaris; Robert A Mooney
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

Review 2.  Muscles, exercise and obesity: skeletal muscle as a secretory organ.

Authors:  Bente K Pedersen; Mark A Febbraio
Journal:  Nat Rev Endocrinol       Date:  2012-04-03       Impact factor: 43.330

Review 3.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 4.  Roles of myokines in exercise-induced improvement of neuropsychiatric function.

Authors:  Sujin Kim; Ji-Young Choi; Sohee Moon; Dong-Ho Park; Hyo-Bum Kwak; Ju-Hee Kang
Journal:  Pflugers Arch       Date:  2019-01-09       Impact factor: 3.657

5.  Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in mice.

Authors:  William D Stuart; Nicholas E Brown; Andrew M Paluch; Susan E Waltz
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-02-03       Impact factor: 4.310

6.  Sexual dimorphism in hypothalamic inflammation in the offspring of dams exposed to a diet rich in high fat and branched-chain amino acids.

Authors:  Marianna Sadagurski; Lucas Kniess Debarba; Joao Pedro Werneck-de-Castro; Abear Ali Awada; Tess A Baker; Ernesto Bernal-Mizrachi
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-30       Impact factor: 4.310

7.  IL6 as a mediator of insulin resistance: fat or fiction?

Authors:  T L Allen; M A Febbraio
Journal:  Diabetologia       Date:  2009-12-10       Impact factor: 10.122

Review 8.  Adipocytokines in obesity and metabolic disease.

Authors:  Haiming Cao
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 9.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

10.  Disassociated relation between plasma tumor necrosis factor-alpha, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose tolerance.

Authors:  Folke Lindgärde; Anders Gottsäter; Bo Ahrén
Journal:  Diabetol Metab Syndr       Date:  2010-06-08       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.